About Us

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio


  The latest news and information about Seattle Cancer Care Alliance.

[ Prev Page / 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 / Next Page ]

May 26, 2015

Here's a list of clinical trials that have opened here at SCCA in the last few weeks. These trials are looking at new treatments for patients with melanoma, clear cell renal cell carcinoma, squamous cell head and neck cancer, patients 65 years or older with acute myelogenous leukemia, patients with myelodysplastic syndrome or chronic myelomonocytic leukemia, and patients with non-small cell lung cancer. Read more.

April 14, 2015

Earlier today, Rita Wilson disclosed to People Magazine in an exclusive statement that she has been recently diagnosed with breast cancer and has undergone bilateral mastectomy and reconstructive surgery. This this post, SCCA’s Dr. VK Gadi provides a detailed discussion of Ms. Wilson’s underlying condition-– LCIS (lobular carcinoma in situ)-–and what treatment options should be considered for women with this condition. Read more.

March 23, 2015

As you may have heard, Premera Blue Cross was recently the target of a sophisticated cyberattack. Seattle Cancer Care Alliance believes patient privacy is of the utmost importance. As a healthcare provider, we want to make sure that any patients who may have been impacted by the Premera cyberattack are aware of possible risks associated with breach and what resources are available to help. Read more

March 11, 2015

Today cancer patients have more treatment options than ever before. We see this every day at SCCA, where there’s a dramatic increase in the pace of innovation. View the progress that we’re making in this year’s annual report. Read more.

March 06, 2015

Dr. Alessandro Fichera is a surgeon who cares for colorectal cancer patients at SCCA. Learn about his childhood growing up in Rome, family history of practicing medicine, and favorite place to go in Washington. Read more.

January 27, 2015

The Fred Hutchinson Cancer Research Center Bone Marrow Transplant Program at SCCA was recently recognized for outperforming its anticipated one-year survival rate for allogeneic transplant patients. The new performance results were calculated by the Center for International Blood and Marrow Transplant Research (CIBMTR).  Read more.

[ Prev Page / 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 / Next Page ]